U.S. President Donald Trump plans to nominate Dr. Stephen Hahn, chief medical executive of the University of Texas MD Anderson Cancer Center, to lead the Food and Drug Administration, the White House said on Friday.
LOS ANGELES Amgen Inc said on Thursday it will take a 20.5% stake in BeiGene Ltd in a deal to expand the California-based biotechnology company's presence in China, the world's second largest pharmaceutical market.
LOS ANGELES, Oct 31 Amgen Inc said on
Thursday it will acquire a 20.5% stake in BeiGene Ltd
in a deal that will enable the California-based biotechnology
company to expand its presence in China, the world's second
largest pharmaceutical market.
Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall Street estimates.
Oct 29 Amgen Inc on Tuesday said
competition for older off-patent drugs sent third-quarter
revenue down 3%, but share repurchases and biosimilar sales
helped it achieve higher-than-expected profit, and the company
raised its full-year outlook.
An experimental drug from Mirati Therapeutics Inc that targets a specific genetic mutation significantly reduced tumor size in 40% of patients with advanced lung and colorectal cancer so far evaluated in a small, early-stage trial, researchers said on Monday.
Gilead Sciences Inc on Thursday posted third-quarter results largely in line with Wall Street estimates, led by higher HIV drug sales, but sales of cancer cell therapy Yescarta fell slightly from the previous quarter.
Oct 24 Gilead Sciences Inc on Thursday
reported third-quarter results largely in line with Wall Street
estimates, led by higher sales of its HIV drugs, but
deal-related costs led to a net loss.
The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's Descovy to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men.